CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 Sonoma Pharma - SNOA CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开仓* N/A
1 年变化* N/A
日范围* N/A
52 周范围 0.76-4.19
平均交易量(10 天) 21.15K
平均交易量(3 个月) 3.03M
市值 4.45M
市盈率 -100.00K
流通股 4.65M
收入 12.56M
EPS -2.19
股息(收益率 %) N/A
贝塔 1.15
下一个财报发布日期 Jul 11, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low

Sonoma Pharma Events

时间(协调世界时) (UTC) 国家/地区 事件
Tuesday, July 11, 2023

时间(协调世界时) (UTC)

20:00

国家/地区

US

事件

Q4 2023 Sonoma Pharmaceuticals Inc Earnings Release
Q4 2023 Sonoma Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Wednesday, August 9, 2023

时间(协调世界时) (UTC)

20:00

国家/地区

US

事件

Q1 2024 Sonoma Pharmaceuticals Inc Earnings Release
Q1 2024 Sonoma Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Friday, September 15, 2023

时间(协调世界时) (UTC)

20:00

国家/地区

US

事件

Sonoma Pharmaceuticals Inc Annual Shareholders Meeting
Sonoma Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, November 13, 2023

时间(协调世界时) (UTC)

21:00

国家/地区

US

事件

Q2 2024 Sonoma Pharmaceuticals Inc Earnings Release
Q2 2024 Sonoma Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 12.628 18.629 17.928 18.97 16.658
收入 12.628 18.629 17.928 18.97 16.658
收入成本,共计 8.417 11.847 9.806 10.09 9.348
毛利 4.211 6.782 8.122 8.88 7.31
总营业费用 17.792 22.078 25.318 30.228 30.847
销售/一般/行政费用,总计 9.755 9.453 14.173 18.62 19.924
研究与开发 0.125 0.555 1.339 1.518 1.575
营业收入 -5.164 -3.449 -7.39 -11.258 -14.189
利息收入(费用),非经营净值 -0.01 0.004 0.034 0.157 0.218
其他,净值 -0.394 -0.594 0.24 -0.239 -0.307
税前净收入 -5.418 -3.902 -3.544 -11.34 -14.278
税后净收入 -5.086 -4.615 -3.573 -11.798 -14.328
未计算非常项目前的净收益 -5.086 -4.615 -3.573 -11.798 -14.328
非常规项目总计 0 0.665 0.265
净收入 -5.086 -3.95 -3.308 -11.798 -14.328
普通股股东可获收益 (不含非经常性项目) -5.086 -4.615 -3.573 -11.798 -14.328
普通股股东可获收益 (含非經常性項目) -5.086 -3.95 -3.308 -11.798 -14.328
摊薄净收入 -5.086 -3.95 -3.308 -11.798 -14.328
摊薄后加权平均股 2.653 1.996 1.477 0.924 0.503
扣除特别项目的每股摊薄盈利 -1.91708 -2.31212 -2.41909 -12.7684 -28.4851
每股正常摊薄盈利 -2.07755 -2.28412 -3.99106 -12.7684 -28.4851
Gain (Loss) on Sale of Assets 0.15 0.137 3.572
异常费用(收入) -0.505 0.223
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
总收入 2.944 3.331 3.983 2.298 2.902
收入 2.944 3.331 3.983 2.298 2.902
收入成本,共计 2.102 1.999 2.32 2.222 1.685
毛利 0.842 1.332 1.663 0.076 1.217
总营业费用 4.778 4.062 4.838 4.635 3.86
销售/一般/行政费用,总计 2.665 2.067 2.295 3.152 2.135
研究与开发 0 0 0.006 0.004 0.026
异常费用(收入) 0.011 -0.004 0.217 -0.743 0.014
营业收入 -1.834 -0.731 -0.855 -2.337 -0.958
利息收入(费用),非经营净值 0.001 0.003 0 -0.009 0.003
Gain (Loss) on Sale of Assets 0.001 0 0 0
其他,净值 -0.073 -0.189 -0.067 -0.936 0.011
税前净收入 -1.905 -0.917 -0.922 -3.282 -0.944
税后净收入 -1.939 -1.017 -0.887 -2.944 -0.944
未计算非常项目前的净收益 -1.939 -1.017 -0.887 -2.944 -0.944
非常规项目总计 0 0
净收入 -1.939 -1.017 -0.887 -2.944 -0.944
普通股股东可获收益 (不含非经常性项目) -1.939 -1.017 -0.887 -2.944 -0.944
普通股股东可获收益 (含非經常性項目) -1.939 -1.017 -0.887 -2.944 -0.944
摊薄净收入 -1.939 -1.017 -0.887 -2.944 -0.944
摊薄后加权平均股 3.107 3.101 3.101 3.091 3.08
扣除特别项目的每股摊薄盈利 -0.62407 -0.32796 -0.28604 -0.95244 -0.30649
每股正常摊薄盈利 -0.62198 -0.3288 -0.24055 -1.10869 -0.30195
Dividends per Share - Common Stock Primary Issue 0 0 0 0
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 16.43 12.983 12.283 12.496 16.254
现金和短期投资 7.396 4.22 3.691 3.689 10.066
现金等价物 7.396 4.22 3.691 3.689 10.066
应收账款总额,净额 4.778 4.656 5.278 4.444 1.752
Accounts Receivable - Trade, Net 2.407 2.806 3.973 3.481 1.537
Total Inventory 2.663 2.53 2.181 3.409 2.865
Prepaid Expenses 1.375 1.368 0.951 0.731 1.332
Other Current Assets, Total 0.218 0.209 0.182 0.223 0.239
Total Assets 18.845 14.987 14.561 14.448 19.206
Property/Plant/Equipment, Total - Net 0.879 1.129 0.724 0.727 1.136
Property/Plant/Equipment, Total - Gross 2.59 2.6 4.326 4.641 4.706
Accumulated Depreciation, Total -1.711 -1.471 -3.602 -3.914 -3.57
Other Long Term Assets, Total 1.536 0.875 1.554 1.225 1.816
Total Current Liabilities 5.819 4.078 4.729 3.591 3.261
Accounts Payable 1.641 1.769 2.067 1.255 1.272
Accrued Expenses 1.309 1.027 1.446 1.236 1.023
Notes Payable/Short Term Debt 0.688 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.12 0.596 0.481 0.463 0.377
Other Current Liabilities, Total 2.061 0.686 0.735 0.637 0.589
Total Liabilities 10.148 9.624 8.937 3.959 3.88
Total Long Term Debt 0 1.31 0 0.012 0.176
Long Term Debt 0 1.31 0 0.012 0.032
Capital Lease Obligations 0 0.144
Other Liabilities, Total 4.329 4.236 4.208 0.356 0.443
Total Equity 8.697 5.363 5.624 10.489 15.326
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.002 0.002 0.002 0.002 0.001
Additional Paid-In Capital 197.37 189.217 186.559 184.074 176.74
Retained Earnings (Accumulated Deficit) -184.363 -179.277 -175.327 -169.238 -157.44
Other Equity, Total -4.312 -4.579 -5.61 -4.349 -3.975
Total Liabilities & Shareholders’ Equity 18.845 14.987 14.561 14.448 19.206
Total Common Shares Outstanding 3.10094 2.09291 1.77748 1.31634 0.68575
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
流动资产总额 11.232 12.393 14.817 16.43 17.699
现金和短期投资 2.634 3.351 5.586 7.396 8.529
现金等价物 2.634 3.351 5.586 7.396 8.529
应收账款总额,净额 2.297 2.487 2.434 2.407 2.854
Accounts Receivable - Trade, Net 2.297 2.487 2.434 2.407 2.854
Total Inventory 2.849 3.025 2.788 2.663 2.879
Prepaid Expenses 3.23 3.315 3.794 3.746 3.226
Other Current Assets, Total 0.222 0.215 0.215 0.218 0.211
Total Assets 13.928 14.962 17.158 18.845 19.347
Property/Plant/Equipment, Total - Net 0.785 0.835 0.787 0.879 0.922
Other Long Term Assets, Total 1.911 1.734 1.554 1.536 0.726
Total Current Liabilities 3.934 3.527 4.854 5.819 3.875
Accounts Payable 1.302 1.074 2.057 1.641 1.583
Accrued Expenses 2.477 2.071 2.185 2.093 1.553
Notes Payable/Short Term Debt 0 0.229 0.459 0.688 0
Current Port. of LT Debt/Capital Leases 0 0 0 0.12 0.587
Other Current Liabilities, Total 0.155 0.153 0.153 1.277 0.152
Total Liabilities 8.369 7.941 9.199 10.148 8.178
Total Long Term Debt 0.015 0.015 0.015 0 0
Long Term Debt 0.015 0.015 0.015 0 0
Other Liabilities, Total 4.42 4.399 4.33 4.329 4.303
Total Equity 5.559 7.021 7.959 8.697 11.169
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.002 0.002 0.002 0.002 0.003
Additional Paid-In Capital 197.939 197.697 197.584 197.37 197.156
Retained Earnings (Accumulated Deficit) -188.206 -186.267 -185.25 -184.363 -181.419
Other Equity, Total -4.176 -4.411 -4.377 -4.312 -4.571
Total Liabilities & Shareholders’ Equity 13.928 14.962 17.158 18.845 19.347
Total Common Shares Outstanding 3.10965 3.10297 3.10094 3.10094 3.09934
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -5.086 -3.95 -2.946 -11.798 -14.328
经营活动产生的现金 -4.248 -3.378 -4.591 -11.717 -12.439
经营活动产生的现金 0.186 0.227 0.312 0.453 0.49
非现金物品 -1.873 -1.039 -0.398 0.894 3.151
已付现金利息 0.024 0.012 0.016 0.033 0.04
营运资金的变化 3.354 1.384 -1.559 -1.266 -1.752
投资活动产生的现金 -0.099 0.388 3.644 -0.131 -0.201
资本支出 -0.137 -0.179 -0.206 -0.1 -0.187
其他投资现金流量项目,总计 0.038 0.567 3.85 -0.031 -0.014
融资活动产生的现金 7.396 3.308 1.029 5.492 5.24
股票的发行(报废),净额 7.77 2.287 1.376 5.97 5.52
债务的发行(退还),净额 -0.374 1.021 -0.347 -0.478 -0.28
外汇效应 0.127 0.211 -0.08 -0.021 0.005
现金净变化 3.176 0.529 0.002 -6.377 -7.395
Cash Taxes Paid 0.767 0.941
Deferred Taxes -0.829
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -3.843 -1.904 -0.887 -5.086 -2.142
Cash From Operating Activities -3.711 -3.363 -1.533 -4.248 -2.853
Cash From Operating Activities 0.091 0.059 0.031 0.186 0.137
Non-Cash Items 0.568 0.327 0.214 -1.873 -0.703
Cash Interest Paid 0.012 0.008 0.004 0.024 0.012
Changes in Working Capital -0.284 -1.706 -0.851 3.354 -0.145
Cash From Investing Activities -0.176 -0.21 -0.023 -0.099 -0.038
Capital Expenditures -0.079 -0.048 -0.023 -0.137 -0.075
Other Investing Cash Flow Items, Total -0.097 -0.162 0.038 0.037
Cash From Financing Activities -0.883 -0.565 -0.387 7.396 7.174
Issuance (Retirement) of Stock, Net 0 0 7.77 7.77
Issuance (Retirement) of Debt, Net -0.794 -0.565 -0.35 -0.374 -0.596
Foreign Exchange Effects 0.008 0.093 0.133 0.127 0.026
Net Change in Cash -4.762 -4.045 -1.81 3.176 4.309
Financing Cash Flow Items -0.089 -0.037
Deferred Taxes -0.243 -0.139 -0.04 -0.829
Cash Taxes Paid 0.055
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Renaissance Technologies LLC Hedge Fund 0.9027 41967 -32500 2023-03-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7789 36214 -541 2023-03-31 LOW
Millennium Management LLC Hedge Fund 0.507 23574 6974 2023-03-31 HIGH
Virtu Americas LLC Research Firm 0.3456 16068 16068 2023-03-31 HIGH
Ground Swell Capital, LLC Investment Advisor 0.2867 13329 13329 2023-03-31 HIGH
Tower Research Capital LLC Hedge Fund 0.1845 8580 520 2023-03-31 HIGH
Birnbaum (Jay E) Individual Investor 0.1234 5739 0 2022-07-22
McLaughlin (Jerry G.) Individual Investor 0.1164 5414 0 2022-07-22
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.0618 2875 0 2023-03-31 LOW
Advisory Services Network, LLC Investment Advisor 0.053 2463 2463 2023-03-31 LOW
Thornton (Bruce) Individual Investor 0.0177 825 0 2022-07-22
JPMorgan Private Bank (United States) Bank and Trust 0.0145 672 672 2023-03-31 LOW
U.S. Bancorp Asset Management, Inc. Investment Advisor 0.0108 500 0 2023-03-31 LOW
Advisor Group, Inc Investment Advisor 0.0046 216 50 2023-03-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.0018 86 0 2023-03-31 LOW
Allworth Financial, L.P. Investment Advisor 0.0014 65 0 2023-03-31 LOW
BofA Global Research (US) Research Firm 0.0009 44 0 2023-03-31 LOW
Gradient Investments LLC Investment Advisor 0.0007 31 0 2023-03-31 MED
Wells Fargo Bank, N.A. Bank and Trust 0.0005 21 0 2023-03-31 LOW
NewSquare Capital LLC Investment Advisor 0.0002 10 0 2023-03-31 MED

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

Sonoma Pharma Company profile

关于 Sonoma Pharma

Sonoma Pharmaceuticals, Inc.从事开发和生产次氯酸(HOCl)产品,其应用范围包括伤口护理、动物保健、眼睛护理、口腔护理和皮肤病。 该公司的产品包括Epicyn抗菌洁面乳、Levicyn抗菌皮肤喷雾剂、Levicyn止痒凝胶、Levicyn止痒喷雾凝胶、Celacyn疤痕管理凝胶和Sebuderm外用凝胶。 其产品主要针对痤疮的治疗、疤痕管理和特应性皮炎。 它还有办公室配药产品,如Lasercyn Dermal Spray、Lasercyn Post Procedure Gel和Regenacyn Advanced Scar Management。 该公司直接或通过合作伙伴在全球约54个国家销售其产品。 其子公司包括Aquamed Technologies, Inc., Oculus Technologies of Mexico, S.A. de C.V. 和Sonoma Pharmaceuticals Netherlands B.V.。

Industry: Pharmaceuticals (NEC)

5445 Conestoga Court, Suite 150
BOULDER
COLORADO 80301
US

收入报表

  • Annual
  • Quarterly

人们也观看

XRP/USD

0.53 Price
-0.410% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00400

BTC/USD

27,319.70 Price
+0.410% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

US100

14,557.80 Price
+0.640% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 3.0

Gold

1,948.36 Price
-1.480% 1D Chg, %
多头隔夜费 -0.0185%
空头隔夜费 0.0103%
隔夜费时间 21:00 (UTC)
价差 0.30

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易